Immunopathological and microbial signatures of inflammatory bowel disease in partial RAG deficiency
Journal of Experimental Medicine · 2025
DOI: 10.1084/jem.20241993 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2025. Verfasst von Riccardo Castagnoli und 50 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, M…. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Homeodomain Proteins. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIDDK NIH HHS, HHS.
Abstract (Originalsprache)
Partial RAG deficiency (pRD) can manifest with systemic and tissue-specific immune dysregulation, with inflammatory bowel disease (IBD) in 15% of the patients. We aimed at identifying the immunopathological and microbial signatures associated with IBD in patients with pRD and in a mouse model of pRD (Rag1w/w) with spontaneous development of colitis. pRD patients with IBD and Rag1w/w mice showed a systemic and colonic Th1/Th17 inflammatory signature. Restriction of fecal microbial diversity, abundance of pathogenic bacteria, and depletion of microbial species producing short-chain fatty acid were observed, which were associated with impaired induction of lamina propria peripheral Treg cells in Rag1w/w mice. The use of vedolizumab in Rag1w/w mice and of ustekinumab in a pRD patient were ineffective. Antibiotics ameliorated gut inflammation in Rag1w/w mice, but only bone marrow transplantation (BMT) rescued the immunopathological and microbial signatures. Our findings shed new light in the pathophysiology of gut inflammation in pRD and establish a curative role for BMT to resolve the disease phenotype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
- Bioinformatics and Computational Biosciences Branch, Office of Cyber Infrastructure and Computational Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, MD, USA.
- Integrated Data Sciences Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
- Research Technologies Branch, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Hamilton, MT, USA.
- Metaorganism Immunity Section, Laboratory of Host Immunity and Microbiome, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
- NIAID Microbiome Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Bethesda, MD, USA.
ORCID-Profile: Riccardo Castagnoli, Francesca Pala, Poorani Subramanian, Cihan Oguz, Benjamin Schwarz, Ai Ing Lim, Andrew S Burns, Elena Fontana, Marita Bosticardo, Cristina Corsino, Angelina Angelova, Ottavia M Delmonte, Heather Kenney, Deanna Riley, Grace Smith, Lisa Ott de Bruin, Vasileios Oikonomou, Lucas Dos Santos Dias, Danielle Fink, Eric Bohrnsen, Cole D Kimzey, Gian Luigi Marseglia, Guisela Alva-Lozada, Jenna R E Bergerson, Ana Brett, Karlla W Brigatti, Dimana Dimitrova, Cullen M Dutmer, Alexandra F Freeman, Hanadys Ale, Steven M Holland, Francesco Licciardi, Srdjan Pasic, Laura E Poskitt, David E Potts, Joseph F Dasso, Svetlana O Sharapova, Kevin A Strauss, Brant R Ward, Melis Yilmaz, Douglas B Kuhns, Michail S Lionakis, Stephen R Daley, Heidi H Kong, Julia A Segre, Anna Villa, Stefania Pittaluga, Ivan Vujkovic-Cvijin, Yasmine Belkaid, Luigi D Notarangelo
Förderung
- NIAID NIH HHS
- NIDDK NIH HHS
- HHS
- National Institute of Allergy and Infectious Diseases
- NHLBI NIH HHS
- Crohn's & Colitis Foundation Career Development
- NIH HHS
- Fondazione Ghislieri
Zitieren
APA
Castagnoli, R., Pala, F., Subramanian, P., Oguz, C., Schwarz, B., Lim, A. I., Burns, A. S., Fontana, E., Bosticardo, M., Corsino, C., Angelova, A., Delmonte, O. M., Kenney, H., Riley, D., Smith, G., Ott de Bruin, L., Oikonomou, V., Dos Santos Dias, L., Fink, D., …, & Notarangelo, L. D. (2025). Immunopathological and microbial signatures of inflammatory bowel disease in partial RAG deficiency. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20241993
Vancouver
Castagnoli R, Pala F, Subramanian P, Oguz C, Schwarz B, Lim AI, et al. Immunopathological and microbial signatures of inflammatory bowel disease in partial RAG deficiency. Journal of Experimental Medicine. 2025. doi:10.1084/jem.20241993
BibTeX
@article{Castagnoli2025,
author = {Castagnoli, Riccardo and Pala, Francesca and Subramanian, Poorani and Oguz, Cihan and Schwarz, Benjamin and Lim, Ai Ing and Burns, Andrew S and Fontana, Elena and Bosticardo, Marita and Corsino, Cristina and Angelova, Angelina and Delmonte, Ottavia M and Kenney, Heather and Riley, Deanna and Smith, Grace and Ott de Bruin, Lisa and Oikonomou, Vasileios and Dos Santos Dias, Lucas and Fink, Danielle and Bohrnsen, Eric and Kimzey, Cole D and Marseglia, Gian Luigi and Alva-Lozada, Guisela and Bergerson, Jenna R E and Brett, Ana and Brigatti, Karlla W and Dimitrova, Dimana and Dutmer, Cullen M and Freeman, Alexandra F and Ale, Hanadys and Holland, Steven M and Licciardi, Francesco and Pasic, Srdjan and Poskitt, Laura E and Potts, David E and Dasso, Joseph F and Sharapova, Svetlana O and Strauss, Kevin A and Ward, Brant R and Yilmaz, Melis and Kuhns, Douglas B and Lionakis, Michail S and Daley, Stephen R and Kong, Heidi H and Segre, Julia A and Villa, Anna and Pittaluga, Stefania and Walter, Jolan E and Vujkovic-Cvijin, Ivan and Belkaid, Yasmine and Notarangelo, Luigi D},
title = {Immunopathological and microbial signatures of inflammatory bowel disease in partial RAG deficiency},
journal = {Journal of Experimental Medicine},
year = {2025},
doi = {10.1084/jem.20241993}
}
EUVIMED